All stock lists
Axsome Therapeutics, Inc. (AXSM)
United States · Delayed Price · Currency is USD
Healthcare
144.33-0.71 (-0.49%)
Insider Score
––Not scored
AXSM Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AXSM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 218.38 M | 191.20 M | 196.00 M | 170.99 M | 150.04 M |
| Revenue Growth (YoY) | 45.54 % | — | — | — | — |
| Cost of Revenue | 13.56 M | 14.72 M | 12.33 M | 11.91 M | 13.45 M |
| Gross Profit | 204.81 M | 176.48 M | 183.67 M | 159.08 M | 136.59 M |
| SG&A Expense | 208.14 M | 185.00 M | 169.30 M | 150.24 M | 130.28 M |
| R&D Expense | 46.23 M | 52.68 M | 48.79 M | 40.16 M | 49.54 M |
| Operating Expenses | 255.95 M | 239.25 M | 219.69 M | 192.00 M | 181.41 M |
| Operating Income | -51.14 M | -62.77 M | -36.02 M | -32.92 M | -44.82 M |
| Pretax Income | -51.19 M | -64.54 M | -28.13 M | -47.23 M | -48.93 M |
| Tax Provision | 128.00 K | 0.00 | 430.00 K | 0.00 | -960.00 K |
| Net Income | -51.31 M | -64.54 M | -28.56 M | -47.23 M | -47.97 M |
| EPS (Basic) | -0.99 | -1.26 | -0.56 | -0.94 | -0.97 |
| EPS (Diluted) | -0.99 | -1.26 | -0.56 | -0.94 | -0.97 |
| Shares Outstanding | 51.80 M | 51.20 M | 50.63 M | 50.02 M | 49.44 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.